Evidence map›Paper›PMID 42099050›Full record

ArticleTransplant infectious disease : an official journal of the Transplantation Society

Microbial Contamination in Deceased Musculoskeletal Tissue Donors: A Large-Scale US Analysis of Infection Risk.

Anthony Montedonico, Kimberly Elliott, Lee Brandenburg, Sara O Dionne

Abstract read
In one paragraph

Article in Transplant infectious disease : an official journal of the Transplantation Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Uses of Human Tissue Bioburden Data.Transplant infectious disease : an official journal of the Transplantation Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anthony MontedonicoEurofins Donor and Product Testing, LLC, Centennial, Colorado, USA.ORCID https://orcid.org/0009-0000-8210-3211
Kimberly ElliottEurofins Donor and Product Testing, LLC, Centennial, Colorado, USA.
Lee BrandenburgEurofins Donor and Product Testing, LLC, Centennial, Colorado, USA.
Sara O DionneEurofins Donor and Product Testing, LLC, Centennial, Colorado, USA.ORCID https://orcid.org/0009-0008-6373-7962

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicrobial contamination of musculoskeletal tissues recovered from deceased donors poses a risk for donor-derived infections and may lead to tissue exclusion under regulatory standards. Despite stringent aseptic protocols, recovery and processing contamination remains a critical challenge. This study presents a large-scale analysis of microbial prevalence and distribution in deceased tissue donors in the United States.

methodsWe conducted a retrospective analysis of 1 186 392 musculoskeletal tissue recovery swabs collected from 69 920 deceased donors between 2019 and 2024. Growth-positive cultures underwent organism identification using MALDI-TOF mass spectrometry and biochemical methods. Microbial findings were stratified by anatomical recovery zone, and organisms considered potentially disqualifying for transplantation were assessed according to American Association of Tissue Banks (AATB) standards.

resultsMicrobial growth was observed in 12.4% of swabs, with 64.8% of donors having at least one growth-positive sample. Among positive swabs, 92.4% yielded bacteria, 5.0% fungi, and 2.6% yielded both. Organisms considered potentially disqualifying were identified in 5.0% of donors, most commonly Clostridium species and Streptococcus pyogenes. The prevalence of virulent organisms varied by anatomical recovery zone, with the highest rates observed in lower extremity and pelvic sites and the lowest in thoracic and vertebral tissues.

conclusionIn this large national cohort, potentially virulent microorganisms were identified in a clinically meaningful proportion of deceased tissue donors, with substantial anatomical variability in contamination risk. These findings reinforce the importance of stringent microbiological screening to reduce the risk of recipient infection while supporting safe and effective tissue transplantation.

Indexed as

Musculoskeletal SystemTissue DonorsAdultAgedBacteriaFemaleFungiHumansMaleMiddle AgedPrevalenceRetrospective StudiesTissue and Organ HarvestingTissue BanksUnited Statesallograftmicroorganismstissue donationvirulence

Identifiers

PMID42099050
PMCPMC13638780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.